Melanie Gaunt says the synthetic cannabinoid nabilone was “a godsend.” Then the company that makes it ran short, a situation one pharmacist says may be tied to the rising demand for alternatives to opioids.
After ‘nightmare’ of pain, woman with MS questions why drug shortages aren’t prevented
